Clinical trials
Phase 1/2 Nasopharyngeal Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2016 | 2 |
| 2019 | 1 |
| 2022 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 3 |
| Recruiting | 2 |
| Completed | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 2 |
| Avenzo Therapeutics, Inc. | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Cullinan Therapeutics Inc. | 1 |
| Fuda Cancer Hospital, Guangzhou | 1 |
| The Second Hospital of Nanjing Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nasopharyngeal Neoplasms | 7 |
| Nasopharyngeal Carcinoma | 3 |
| Biliary Tract Neoplasms | 1 |
| Carcinoma | 1 |
| Epstein-Barr Virus Infections | 1 |
| Lung Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Small Cell Lung Carcinoma | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.